Free Trial

UnitedHealth Group (NYSE:UNH) Given New $362.00 Price Target at Barclays

UnitedHealth Group logo with Medical background

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price objective reduced by equities researchers at Barclays from $513.00 to $362.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has an "overweight" rating on the healthcare conglomerate's stock. Barclays's price target would indicate a potential upside of 17.40% from the stock's previous close.

A number of other analysts have also recently issued reports on UNH. Robert W. Baird cut their target price on shares of UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating for the company in a research note on Wednesday. Truist Financial dropped their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a research note on Monday, April 21st. HSBC restated a "hold" rating and set a $490.00 target price on shares of UnitedHealth Group in a research report on Tuesday, April 22nd. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research report on Wednesday. Finally, Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Six analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $508.38.

Check Out Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Trading Down 1.0%

UnitedHealth Group stock opened at $308.35 on Thursday. The business has a 50 day moving average price of $478.83 and a two-hundred day moving average price of $517.83. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $279.72 billion, a price-to-earnings ratio of 19.89, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. UnitedHealth Group has a 12 month low of $278.56 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the business posted $6.91 earnings per share. As a group, equities analysts forecast that UnitedHealth Group will post 29.54 EPS for the current year.

Institutional Trading of UnitedHealth Group

A number of institutional investors have recently made changes to their positions in the stock. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $28,000. Bayforest Capital Ltd raised its stake in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Finally, AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth about $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines